Innate immune effector recruiting potential of HIV-1 human vaccine induced antibodies

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1036470

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A HIV vaccine is urgently needed. A recent human HIV vaccine trial has indicated that Antibody Dependent Cellular Cyotoxicity (ADCC) may be protective. Understanding the role of ADCC HIV-specific antibodies in the context of vaccination has now become one of the most critical questions in HIV vaccine research today. This research aims to comprehensively study ADCC in samples from various HIV Vaccine trials to develop improved vaccine strategies to prevent the devastating consequences of HIV/AIDS.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2017

Funding Scheme: Early Career Fellowships

Funding Amount: $333,018.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Humoural Immunology and Immunochemistry

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody | human immunodeficiency virus (HIV) | innate immunity | natural killer cells | vaccine

Related Links